246 related articles for article (PubMed ID: 28081671)
21. Impact of serogroup A meningococcal conjugate vaccine for Africa.
Stuart JM
Hum Vaccin Immunother; 2018 May; 14(5):1116-1117. PubMed ID: 29194010
[TBL] [Abstract][Full Text] [Related]
22. Meningococcal carriage in the African meningitis belt.
MenAfriCar Consortium
Trop Med Int Health; 2013 Aug; 18(8):968-78. PubMed ID: 23682910
[TBL] [Abstract][Full Text] [Related]
23. Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.
Brynildsrud OB; Eldholm V; Bohlin J; Uadiale K; Obaro S; Caugant DA
Proc Natl Acad Sci U S A; 2018 May; 115(21):5510-5515. PubMed ID: 29735685
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac
Viviani S
Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455366
[TBL] [Abstract][Full Text] [Related]
25. [Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].
Chippaux JP; Debois H; Saliou P
Bull Soc Pathol Exot; 2002 Mar; 95(1):37-44. PubMed ID: 12012963
[TBL] [Abstract][Full Text] [Related]
26. Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
Micoli F; Romano MR; Tontini M; Cappelletti E; Gavini M; Proietti D; Rondini S; Swennen E; Santini L; Filippini S; Balocchi C; Adamo R; Pluschke G; Norheim G; Pollard A; Saul A; Rappuoli R; MacLennan CA; Berti F; Costantino P
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19077-82. PubMed ID: 24191022
[TBL] [Abstract][Full Text] [Related]
27. "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa.
Robbins JB; Towne DW; Gotschlich EC; Schneerson R
Lancet; 1997 Sep; 350(9081):880-2. PubMed ID: 9310615
[TBL] [Abstract][Full Text] [Related]
28. An evaluation of emerging vaccines for childhood meningococcal disease.
Choudhuri D; Huda T; Theodoratou E; Nair H; Zgaga L; Falconer R; Luksic I; Johnson HL; Zhang JS; El Arifeen S; Nelson CB; Borrow R; Campbell H; Rudan I
BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S29. PubMed ID: 21501447
[TBL] [Abstract][Full Text] [Related]
29. Technical Development of a New Meningococcal Conjugate Vaccine.
Frasch CE; Kapre SV; Lee CH; Préaud JM
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S404-9. PubMed ID: 26553667
[TBL] [Abstract][Full Text] [Related]
30. The burden of meningococcal meningitis in the African Meningitis Belt, from 2009 to 2014: a trend analysis.
Jaca A; Wiyeh AB; Sambala EZ; Wiysonge CS
Pan Afr Med J; 2021; 39():57. PubMed ID: 34422180
[TBL] [Abstract][Full Text] [Related]
31. [From genomics to surveillance, prevention and control: new challenges for the African meningitis belt].
Alonso JM; Bertherat E; Perea W; Borrow R; Chanteau S; Cohet C; Dodet B; Greenwood B; LaForce FM; Muros-Le Rouzic E; Teyssou R; Ouédraogo-Traoré R; Sow I
Bull Soc Pathol Exot; 2006 Dec; 99(5):404-8. PubMed ID: 17253061
[TBL] [Abstract][Full Text] [Related]
32. Meningococcal vaccine in travelers.
Wilder-Smith A
Curr Opin Infect Dis; 2007 Oct; 20(5):454-60. PubMed ID: 17762777
[TBL] [Abstract][Full Text] [Related]
33. Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018.
Bwaka A; Bita A; Lingani C; Fernandez K; Durupt A; Mwenda JM; Mihigo R; Djingarey MH; Ronveaux O; Preziosi MP
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S140-S147. PubMed ID: 31671448
[TBL] [Abstract][Full Text] [Related]
34. A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
Manigart O; Trotter C; Findlow H; Assefa A; Mihret W; Moti Demisse T; Yeshitela B; Osei I; Hodgson A; Quaye SL; Sow S; Coulibaly M; Diallo K; Traore A; Collard JM; Moustapha Boukary R; Djermakoye O; Mahamane AE; Jusot JF; Sokhna C; Alavo S; Doucoure S; Ba el H; Dieng M; Diallo A; Daugla DM; Omotara B; Chandramohan D; Hassan-King M; Nascimento M; Woukeu A; Borrow R; Stuart JM; Greenwood B
PLoS One; 2016; 11(2):e0147928. PubMed ID: 26872255
[TBL] [Abstract][Full Text] [Related]
35. Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt.
Carod Artal FJ
Int Health; 2015 Jul; 7(4):226-7. PubMed ID: 25878213
[TBL] [Abstract][Full Text] [Related]
36. Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study.
Arifin SMN; Zimmer C; Trotter C; Colombini A; Sidikou F; LaForce FM; Cohen T; Yaesoubi R
Med Decis Making; 2019 Jul; 39(5):553-567. PubMed ID: 31268405
[No Abstract] [Full Text] [Related]
37. MenAfriNet: A Network Supporting Case-Based Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Africa.
Patel JC; Soeters HM; Diallo AO; Bicaba BW; Kadadé G; Dembélé AY; Acyl MA; Nikiema C; Lingani C; Hatcher C; Acosta AM; Thomas JD; Diomande F; Martin S; Clark TA; Mihigo R; Hajjeh RA; Zilber CH; Aké F; Mbaeyi SA; Wang X; Moisi JC; Ronveaux O; Mwenda JM; Novak RT;
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S148-S154. PubMed ID: 31671453
[TBL] [Abstract][Full Text] [Related]
38. Meningitis epidemics shift in sub-Saharan belt.
Zhao S; Lin Q; He D; Stone L
Int J Infect Dis; 2018 Mar; 68():79-82. PubMed ID: 29408359
[TBL] [Abstract][Full Text] [Related]
39. Meningococcal conjugate vaccines.
Zimmer SM; Stephens DS
Expert Opin Pharmacother; 2004 Apr; 5(4):855-63. PubMed ID: 15102568
[TBL] [Abstract][Full Text] [Related]
40. Trends in Neisseria meningitidis serogroups amongst patients with suspected cerebrospinal meningitis in the meningitis belt of Ghana: a 5-year retrospective study.
Azure S; Abdul-Karim A; Abubakari BB; Eleeza JB; Agboyie DDA; Weyori EW; Choi JY
BMC Infect Dis; 2023 Apr; 23(1):202. PubMed ID: 37024833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
